315 related articles for article (PubMed ID: 21900218)
1. Esophageal and esophagogastric junction cancers.
Ajani JA; Barthel JS; Bentrem DJ; D'Amico TA; Das P; Denlinger CS; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hofstetter WL; Ilson DH; Keswani RN; Kleinberg LR; Korn WM; Lockhart AC; Mulcahy MF; Orringer MB; Osarogiagbon RU; Posey JA; Sasson AR; Scott WJ; Shibata S; Strong VE; Varghese TK; Warren G; Washington MK; Willett C; Wright CD;
J Natl Compr Canc Netw; 2011 Aug; 9(8):830-87. PubMed ID: 21900218
[No Abstract] [Full Text] [Related]
2. Early diagnosis and management of esophageal and gastric cancer.
Lang GD; Konda VJ
Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
[TBL] [Abstract][Full Text] [Related]
3. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
[No Abstract] [Full Text] [Related]
4. Adjuvant (postoperative) therapy for esophageal cancer.
Ku GY; Ilson DH
Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
[TBL] [Abstract][Full Text] [Related]
5. [CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS].
Bišof V; Juretić A; Stančić-Rokotov D; Rustemović N; Miletić D; Boban M; Omrčen T; Razumović JJ; Pavlović I; Fröbe A; Čonkaš M; Rakušić Z; Gugić D
Lijec Vjesn; 2016; 138(9-10):233-9. PubMed ID: 30148543
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for Esophageal Adenocarcinoma.
Lam KO; Kwong DLW
Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
[TBL] [Abstract][Full Text] [Related]
7. [Histological classification: evaluation of resection specimens of EMR/ESD--response evaluation after neoadjuvant therapy].
Munding J; Ziebarth W; Belyaev O; Uhl W; Tannapfel A
Zentralbl Chir; 2013 Dec; 138 Suppl 2():e55-62. PubMed ID: 22025359
[TBL] [Abstract][Full Text] [Related]
8. Modern approaches to localized cancer of the esophagus.
Glasgow RE; Ilson DH; Hayman JA; Gerdes H; Mulcahy MF; Ajani JA
J Natl Compr Canc Netw; 2011 Aug; 9(8):902-11. PubMed ID: 21900220
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary Therapy of Esophageal Cancer.
Egyud MR; Tseng JF; Suzuki K
Surg Clin North Am; 2019 Jun; 99(3):419-437. PubMed ID: 31047033
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches to gastroesophageal junction adenocarcinomas.
Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R
Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026
[TBL] [Abstract][Full Text] [Related]
11. Multimodal therapy for esophageal adenocarcinoma.
Badwe RA; Vaidya JS; Bhansali MS
N Engl J Med; 1997 Jan; 336(5):374-5; author reply 375-6. PubMed ID: 9011794
[No Abstract] [Full Text] [Related]
12. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
13. Therapy for esophageal cancer.
Heath EI; Forastiere AA
Cancer Treat Res; 2001; 105():387-98. PubMed ID: 11224996
[No Abstract] [Full Text] [Related]
14. Early detection and management of esophageal cancer.
Margulies C; Kim R; Reynolds JC
Compr Ther; 1996 Sep; 22(9):565-78. PubMed ID: 8902348
[No Abstract] [Full Text] [Related]
15. Ring-enhancing lesion associated with radiation-induced liver disease.
Iwasa S; Mayahara H; Tanaka T; Ito Y
J Clin Oncol; 2013 May; 31(14):e243-4. PubMed ID: 23547082
[No Abstract] [Full Text] [Related]
16. Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.
Anghel R; Constantinoiu S; Bacinschi X; Gales L; Toma RV; Trifanescu O
Chirurgia (Bucur); 2018; 113(1):116-122. PubMed ID: 29509538
[No Abstract] [Full Text] [Related]
17. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
18. Management of gastroesophageal junction tumors.
Fox MP; van Berkel V
Surg Clin North Am; 2012 Oct; 92(5):1199-212. PubMed ID: 23026278
[TBL] [Abstract][Full Text] [Related]
19. Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
Nabavizadeh N; Shukla R; Elliott DA; Mitin T; Vaccaro GM; Dolan JP; Maggiore RJ; Schipper PH; Hunter JG; Thomas CR; Holland JM
Dis Esophagus; 2016 Aug; 29(6):614-20. PubMed ID: 26043837
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
